BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 16810722)

  • 41. Globus pallidus stimulation in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    J Clin Neurosci; 2007 Mar; 14(3):208-15. PubMed ID: 17150360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 2-dimensional magnetic resonance imaging and 3-planar reconstruction methods for targeting the subthalamic nucleus in Parkinson disease.
    Andrade-Souza YM; Schwalb JM; Hamani C; Hoque T; Saint-Cyr J; Lozano AM
    Surg Neurol; 2005 Apr; 63(4):357-62; discussion 362-3. PubMed ID: 15808723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia.
    Cersosimo MG; Raina GB; Benarroch EE; Piedimonte F; Alemán GG; Micheli FE
    Mov Disord; 2009 Jul; 24(10):1488-93. PubMed ID: 19475579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.
    Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D
    Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of anterior commissure-posterior commissure-based target calculation of the subthalamic nucleus in functional stereotactic procedures.
    Acar F; Miller JP; Berk MC; Anderson G; Burchiel KJ
    Stereotact Funct Neurosurg; 2007; 85(6):287-91. PubMed ID: 17709981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation.
    Accolla E; Caputo E; Cogiamanian F; Tamma F; Mrakic-Sposta S; Marceglia S; Egidi M; Rampini P; Locatelli M; Priori A
    Mov Disord; 2007 Jun; 22(8):1150-6. PubMed ID: 17469208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectral analysis of field potential recordings by deep brain stimulation electrode for localization of subthalamic nucleus in patients with Parkinson's disease.
    Miyagi Y; Okamoto T; Morioka T; Tobimatsu S; Nakanishi Y; Aihara K; Hashiguchi K; Murakami N; Yoshida F; Samura K; Nagata S; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(4):211-8. PubMed ID: 19571612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Deep brain stimulation in the treatment of movement disorders].
    Goto S
    Rinsho Shinkeigaku; 2007 Nov; 47(11):948-50. PubMed ID: 18210844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of frame-based stereotactic magnetic resonance imaging vs frame-based stereotactic head computed tomography fused with recent magnetic resonance imaging for postimplantation deep brain stimulator lead localization.
    Pezeshkian P; DeSalles AA; Gorgulho A; Behnke E; McArthur D; Bari A
    Neurosurgery; 2011 Dec; 69(6):1299-306. PubMed ID: 21725253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording.
    Reck C; Maarouf M; Wojtecki L; Groiss SJ; Florin E; Sturm V; Fink GR; Schnitzler A; Timmermann L
    J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):377-86. PubMed ID: 23042143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parkinson's disease and deep brain stimulator placement.
    Deiner S; Hagen J
    Anesthesiol Clin; 2009 Sep; 27(3):391-415, table of contents. PubMed ID: 19825483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement.
    Bezchlibnyk YB; Sharma VD; Naik KB; Isbaine F; Gale JT; Cheng J; Triche SD; Miocinovic S; Buetefisch CM; Willie JT; Boulis NM; Factor SA; Wichmann T; DeLong MR; Gross RE
    J Neurosurg; 2020 Mar; 134(3):1072-1082. PubMed ID: 32114534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei.
    Zhu XL; Hamel W; Schrader B; Weinert D; Hedderich J; Herzog J; Volkmann J; Deuschl G; Müller D; Mehdorn HM
    Acta Neurochir (Wien); 2002 Oct; 144(10):959-69; discussion 968-9. PubMed ID: 12382123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilateral subthalamic deep brain stimulation after bilateral pallidal deep brain stimulation for Parkinson's disease.
    Deogaonkar M; Monsalve GA; Scott J; Ahmed A; Rezai A
    Stereotact Funct Neurosurg; 2011; 89(2):123-7. PubMed ID: 21336008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Indication of surgical therapy for Parkinson's disease].
    Katayama Y; Kobayashi K
    Nihon Rinsho; 2004 Sep; 62(9):1691-5. PubMed ID: 15462386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria.
    Benabid AL; Krack PP; Benazzouz A; Limousin P; Koudsie A; Pollak P
    Neurology; 2000; 55(12 Suppl 6):S40-4. PubMed ID: 11188974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.